High serum cytokine levels may predict the responsiveness of patients with severe asthma to benralizumab.

Objective: Benralizumab, a humanized monoclonal antibody against human IL-5 receptor alpha, is effective in treating eosinophilic severe asthma. However, patients’ response to benralizumab varies w...